JP2013515268A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515268A5 JP2013515268A5 JP2012546149A JP2012546149A JP2013515268A5 JP 2013515268 A5 JP2013515268 A5 JP 2013515268A5 JP 2012546149 A JP2012546149 A JP 2012546149A JP 2012546149 A JP2012546149 A JP 2012546149A JP 2013515268 A5 JP2013515268 A5 JP 2013515268A5
- Authority
- JP
- Japan
- Prior art keywords
- epithelial cells
- glomerular epithelial
- therapy
- urinary
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 63
- 210000002919 epithelial cell Anatomy 0.000 claims description 50
- 230000001434 glomerular Effects 0.000 claims description 50
- 238000002560 therapeutic procedure Methods 0.000 claims description 38
- 230000002485 urinary effect Effects 0.000 claims description 34
- 201000001474 proteinuria Diseases 0.000 claims description 24
- 210000002700 urine Anatomy 0.000 claims description 21
- 238000011123 anti-EGFR therapy Methods 0.000 claims description 8
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 claims description 6
- 239000002147 L01XE04 - Sunitinib Substances 0.000 claims description 6
- 239000005511 L01XE05 - Sorafenib Substances 0.000 claims description 6
- 229960000397 bevacizumab Drugs 0.000 claims description 6
- 238000000684 flow cytometry Methods 0.000 claims description 6
- 229960003787 sorafenib Drugs 0.000 claims description 6
- 229960001796 sunitinib Drugs 0.000 claims description 6
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 4
- 241000282412 Homo Species 0.000 claims description 3
- 210000000557 podocyte Anatomy 0.000 claims description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28851409P | 2009-12-21 | 2009-12-21 | |
| US61/288,514 | 2009-12-21 | ||
| PCT/US2010/061543 WO2011084791A2 (en) | 2009-12-21 | 2010-12-21 | Early marker of proteinuria in patients treated with an anti-vegf treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515268A JP2013515268A (ja) | 2013-05-02 |
| JP2013515268A5 true JP2013515268A5 (enExample) | 2014-02-06 |
| JP5753541B2 JP5753541B2 (ja) | 2015-07-22 |
Family
ID=44306097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546149A Expired - Fee Related JP5753541B2 (ja) | 2009-12-21 | 2010-12-21 | 抗ｖｅｇｆ治療によって治療された患者におけるタンパク尿の初期マーカー |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20130034861A1 (enExample) |
| EP (1) | EP2517014B1 (enExample) |
| JP (1) | JP5753541B2 (enExample) |
| AU (1) | AU2010339723B2 (enExample) |
| BR (1) | BR112012017767A2 (enExample) |
| CA (1) | CA2785273A1 (enExample) |
| ES (1) | ES2530866T3 (enExample) |
| WO (1) | WO2011084791A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090104649A1 (en) | 2007-06-11 | 2009-04-23 | Garovic Vesna D | Markers for preeclampsia |
| BR112012017767A2 (pt) | 2009-12-21 | 2019-09-24 | Mayo Found Medical Education & Res | marcador precoce de proteinúria em pacientes tratados com um tratamento anti-vegf |
| JP6310861B2 (ja) * | 2012-12-26 | 2018-04-11 | 原 正則 | 尿中ポドサイトの検出方法 |
| US11028448B2 (en) | 2019-09-20 | 2021-06-08 | The University Of North Carolina At Chapel Hill | Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9306053D0 (en) | 1993-03-24 | 1993-05-12 | Nycomed Pharma As | Method and assay |
| EP1336845B1 (en) | 2000-10-27 | 2013-03-27 | DENKA SEIKEN Co., Ltd. | Method of diagnosing nephropathy |
| US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| WO2003075016A1 (en) | 2002-03-07 | 2003-09-12 | Cambridge University Technical Services Limited (Cuts) | Scd fingerprints |
| US20030198959A1 (en) * | 2002-03-28 | 2003-10-23 | Kurnit David M. | Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| GB0215509D0 (en) * | 2002-07-04 | 2002-08-14 | Novartis Ag | Marker genes |
| US7435419B2 (en) | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| JP2007532913A (ja) | 2004-04-16 | 2007-11-15 | ユニバーシティー オブ マサチューセッツ | 細胞内病原体の検出法および定量化法 |
| AU2005277350A1 (en) * | 2004-08-17 | 2006-03-02 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Method of pre-selecting patients for anti-vegf, anti-hif-1 or anti-thioredoxin therapy |
| US7790463B2 (en) | 2006-02-02 | 2010-09-07 | Yale University | Methods of determining whether a pregnant woman is at risk of developing preeclampsia |
| US7820159B2 (en) * | 2006-10-31 | 2010-10-26 | Instiute of Virology of the Slovak Academy of Sciences | MN/CA IX and EGFR pathway inhibition |
| CA2672560A1 (en) * | 2006-12-15 | 2008-06-26 | Ruprecht-Karls-Universitaet Heidelberg | Methods for treating podocyte-related disorders |
| KR20150041157A (ko) | 2007-05-21 | 2015-04-15 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | 소변으로부터의 전구 세포 및 이를 사용하는 방법 |
| US20090104649A1 (en) | 2007-06-11 | 2009-04-23 | Garovic Vesna D | Markers for preeclampsia |
| US20090068683A1 (en) | 2007-06-11 | 2009-03-12 | Mayo Foundation For Medical Education And Research | Markers for preeclampsia |
| WO2009053987A1 (en) * | 2007-10-25 | 2009-04-30 | University Of Bristol | Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf) |
| WO2010065968A1 (en) | 2008-12-05 | 2010-06-10 | Myriad Genetics, Inc. | Cancer detection markers |
| WO2010143423A1 (ja) | 2009-06-10 | 2010-12-16 | 国立大学法人 新潟大学 | 糖尿病性腎症の検査方法 |
| BR112012017767A2 (pt) | 2009-12-21 | 2019-09-24 | Mayo Found Medical Education & Res | marcador precoce de proteinúria em pacientes tratados com um tratamento anti-vegf |
| NZ603482A (en) | 2010-05-12 | 2014-11-28 | Tengion Inc | Bioactive renal cells |
| EP2856164B1 (en) | 2012-06-01 | 2018-07-11 | Mayo Foundation For Medical Education And Research | High-throughput early detection and point-of-care early detection of pregnant women susceptible to developing preeclampsia |
| EP2904118B1 (en) | 2012-10-05 | 2019-03-20 | Hitachi Chemical Co., Ltd. | Urine exosome mrnas and methods of using same to detect diabetic nephropathy |
| WO2015080838A1 (en) | 2013-11-27 | 2015-06-04 | Mayo Foundation For Medical Education And Research | Detecting podocyte injury in diabetic nephropathy and glomerulonephritis |
-
2010
- 2010-12-21 BR BR112012017767A patent/BR112012017767A2/pt not_active IP Right Cessation
- 2010-12-21 US US13/518,358 patent/US20130034861A1/en not_active Abandoned
- 2010-12-21 EP EP10842718.8A patent/EP2517014B1/en not_active Not-in-force
- 2010-12-21 JP JP2012546149A patent/JP5753541B2/ja not_active Expired - Fee Related
- 2010-12-21 ES ES10842718T patent/ES2530866T3/es active Active
- 2010-12-21 WO PCT/US2010/061543 patent/WO2011084791A2/en not_active Ceased
- 2010-12-21 AU AU2010339723A patent/AU2010339723B2/en not_active Ceased
- 2010-12-21 CA CA2785273A patent/CA2785273A1/en not_active Abandoned
-
2013
- 2013-05-20 US US13/898,124 patent/US9213038B2/en active Active
-
2015
- 2015-11-09 US US14/935,784 patent/US9765137B2/en active Active
-
2017
- 2017-09-13 US US15/703,676 patent/US10336822B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| ATE452343T1 (de) | Verbesserte vitamin-d-messung | |
| WO2008109075A3 (en) | Biomarkers and methods for determining sensitivity to ctla-4 antagonists | |
| NO20083820L (no) | Deteksjon av kreft ved forhoyede nivaer av BCL-2 | |
| WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
| WO2012035296A3 (en) | Assay for prions | |
| NZ701807A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2002046746A3 (en) | Method for detection of vitamin d metabolites | |
| WO2010002911A3 (en) | Methods and materials for monitoring myeloma using quantitative mass spetrometry | |
| WO2007090126A3 (en) | Compositions and methods for detecting and quantifying toxic substances in disease states | |
| NZ609824A (en) | Immunochromatography devices, methods and kits | |
| WO2008063663A3 (en) | Poly (ethylene glycol) anti-body detection assays and kits for performing thereof | |
| JP2013515268A5 (enExample) | ||
| JP5184554B2 (ja) | 検出対象の検出方法及び定量方法 | |
| McNabb et al. | Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus | |
| WO2010051544A3 (en) | Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer | |
| WO2013036754A3 (en) | Methods and compositions for diagnosis of ovarian cancer | |
| WO2007126901A3 (en) | Apparatus and method for predicting disease | |
| WO2007035834A3 (en) | Methods and systems for creating a recipe for a defect review process | |
| WO2009111572A3 (en) | Cell, method and kit for conducting an assay for neutralizing antibodies | |
| WO2010097553A3 (fr) | Procédé de diagnostic d'une vascularite | |
| JP2011209281A5 (enExample) | ||
| FR2900936B1 (fr) | Procede et methodes de detection de la maladie d'alzheimer | |
| WO2003101176A3 (en) | Method, composition and kit for antigenic binding of norwalk-like viruses | |
| CN104053994B (zh) | 测定 |